Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures. TRIUMPH-1 randomized 2,339 participants to receive either retatrutide 4 mg, 9 mg, 12 mg, or placebo
Clin Ther 37:2086-2103.e10
Depending on medical appropriateness and availability, Flow Wellness providers may discuss semaglutide, tirzepatide, oral GLP-1 options, or other weight-management strategies
Neuroscience Letters 486 (1): 38-42
The important nuance is that energy is a pathway to behavior change, not a direct metabolic weapon against fat
Many researchers use a clock pattern around the abdomen, moving to the next hour position each week